Skip to main content
Top
Published in: Strahlentherapie und Onkologie 4/2024

Open Access 04-10-2023 | Radiotherapy | Original Article

Intraoperative radiotherapy (IORT) of early breast cancer with low-energy x-rays in breast-conserving surgery

Prospective identification of pre- and intraoperative factors influencing the feasibility of IORT

Authors: Anja Grimm, MD, Eva Wollmann, Elena Sperk, Christel Weiß, Marc Sütterlin, Sebastian Berlit, Benjamin Tuschy

Published in: Strahlentherapie und Onkologie | Issue 4/2024

Login to get access

Abstract

Purpose

The aim of this study is to identify pre- and intraoperative factors indicating the feasibility of intraoperative radiotherapy (IORT) during breast-conserving surgery (BCS).

Materials and methods

From January 2018 to December 2019, a total of 128 women undergoing BCS due to early breast cancer were included in this prospective observational study, independent of whether IORT was planned or not. Patient and tumor characteristics as well as surgical parameters that could potentially influence the feasibility of IORT were recorded for the entire collective. In addition, a preoperative senological assessment was performed and analyzed to assess the feasibility of IORT. Logistic regression was then used to identify relevant preoperative parameters and to generate a formula predicting the feasibility of IORT.

Results

Of the 128 included women undergoing BCS, 46 were preoperatively rated to be feasible, 20 to be questionably feasible for IORT. Ultimately, IORT was realized in 30 patients. The most frequent reasons for omission of IORT were insufficient tumor-to-skin distance and/or an excessively large tumor cavity. Small clinical tumor size and large tumor-to-skin distance according to preoperative ultrasound were significantly related to accomplishment of IORT.

Conclusion

We observed that preoperative ultrasound-based tumor–skin distance is a significant factor in addition to already known parameters to predict feasibility of IORT. Based on our findings we developed a formula to optimize IORT planning which might serve as an additional tool to improve patient selection for IORT in early breast cancer.
Appendix
Available only for authorised users
Literature
2.
go back to reference Rojas K, Stuckey A (2016) Breast cancer epidemiology and risk factors. Clin Obstet Gynecol 59:651–672CrossRefPubMed Rojas K, Stuckey A (2016) Breast cancer epidemiology and risk factors. Clin Obstet Gynecol 59:651–672CrossRefPubMed
4.
go back to reference Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P et al (2013) DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189:825–833CrossRefPubMedPubMedCentral Sedlmayer F, Sautter-Bihl ML, Budach W, Dunst J, Fastner G, Feyer P et al (2013) DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer. Strahlenther Onkol 189:825–833CrossRefPubMedPubMedCentral
5.
go back to reference Shah C, Badiyan S, Wilkinson BJ, Vicini F, Beitsch P, Keisch M et al (2013) Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial. Ann Surg Oncol 20:3279–3285CrossRefPubMed Shah C, Badiyan S, Wilkinson BJ, Vicini F, Beitsch P, Keisch M et al (2013) Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial. Ann Surg Oncol 20:3279–3285CrossRefPubMed
6.
go back to reference Polgar C, Fodor J, Major T, Sulyok Z, Kasler M (2013) Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108:197–202CrossRefPubMed Polgar C, Fodor J, Major T, Sulyok Z, Kasler M (2013) Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. Radiother Oncol 108:197–202CrossRefPubMed
7.
go back to reference Pashtan IM, Recht A, Ancukiewicz M, Brachtel E, Abi-Raad RF, D’Alessandro HA et al (2012) External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5‑year results of a prospective study. Int J Radiat Oncol Biol Phys 84:e271–e277CrossRefPubMedPubMedCentral Pashtan IM, Recht A, Ancukiewicz M, Brachtel E, Abi-Raad RF, D’Alessandro HA et al (2012) External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5‑year results of a prospective study. Int J Radiat Oncol Biol Phys 84:e271–e277CrossRefPubMedPubMedCentral
8.
go back to reference Lemanski C, Azria D, Gourgou-Bourgade S, Ailleres N, Pastant A, Rouanet P et al (2013) Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial. Radiat Oncol 8:191CrossRefPubMedPubMedCentral Lemanski C, Azria D, Gourgou-Bourgade S, Ailleres N, Pastant A, Rouanet P et al (2013) Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial. Radiat Oncol 8:191CrossRefPubMedPubMedCentral
9.
go back to reference Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:1269–1277CrossRefPubMed Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C et al (2013) Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol 14:1269–1277CrossRefPubMed
10.
go back to reference Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT‑A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91–102CrossRefPubMed Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C et al (2010) Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT‑A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet 376:91–102CrossRefPubMed
11.
go back to reference Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5‑year results for local control and overall survival from the TARGIT‑A randomised trial. Lancet 383:603–613CrossRefPubMed Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M et al (2014) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5‑year results for local control and overall survival from the TARGIT‑A randomised trial. Lancet 383:603–613CrossRefPubMed
12.
go back to reference Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P et al (2021) Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol 22:597–608CrossRefPubMed Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P et al (2021) Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol 22:597–608CrossRefPubMed
13.
go back to reference Polgar C, Van Limbergen E, Potter R, Kovacs G, Polo A, Lyczek J et al (2010) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 94:264–273CrossRefPubMed Polgar C, Van Limbergen E, Potter R, Kovacs G, Polo A, Lyczek J et al (2010) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 94:264–273CrossRefPubMed
14.
go back to reference Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM et al (2017) Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol 7:73–79CrossRefPubMed Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM et al (2017) Accelerated partial breast irradiation: Executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol 7:73–79CrossRefPubMed
15.
go back to reference Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S et al (2021) New clinical and biological insights from the international TARGIT‑A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Br J Cancer 125:380–389CrossRefPubMedPubMedCentral Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S et al (2021) New clinical and biological insights from the international TARGIT‑A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Br J Cancer 125:380–389CrossRefPubMedPubMedCentral
16.
go back to reference Vaidya JS, Bulsara M, Baum M, Tobias JS, authors T‑At (2021) Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment. Br J Cancer 124:1469–1474CrossRefPubMedPubMedCentral Vaidya JS, Bulsara M, Baum M, Tobias JS, authors T‑At (2021) Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment. Br J Cancer 124:1469–1474CrossRefPubMedPubMedCentral
17.
go back to reference Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S et al (2020) Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT‑A randomised clinical trial. BMJ 370:m2836CrossRefPubMedPubMedCentral Vaidya JS, Bulsara M, Baum M, Wenz F, Massarut S, Pigorsch S et al (2020) Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT‑A randomised clinical trial. BMJ 370:m2836CrossRefPubMedPubMedCentral
18.
go back to reference Vavassori A, Tagliaferri L, Vicenzi L, D’Aviero A, Ciabattoni A, Gribaudo S et al (2020) Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic—A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group. Radiother Oncol 149:73–77CrossRefPubMedPubMedCentral Vavassori A, Tagliaferri L, Vicenzi L, D’Aviero A, Ciabattoni A, Gribaudo S et al (2020) Practical indications for management of patients candidate to Interventional and Intraoperative Radiotherapy (Brachytherapy, IORT) during COVID-19 pandemic—A document endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy Working Group. Radiother Oncol 149:73–77CrossRefPubMedPubMedCentral
19.
go back to reference Blank E, Kraus-Tiefenbacher U, Welzel G, Keller A, Bohrer M, Sutterlin M et al (2010) Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x‑rays. Ann Surg Oncol 17(Suppl 3):352–358CrossRefPubMed Blank E, Kraus-Tiefenbacher U, Welzel G, Keller A, Bohrer M, Sutterlin M et al (2010) Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x‑rays. Ann Surg Oncol 17(Suppl 3):352–358CrossRefPubMed
20.
go back to reference Pez M, Keller A, Welzel G, Abo-Madyan Y, Ehmann M, Tuschy B et al (2020) Long-term outcome after intraoperative radiotherapy as a boost in breast cancer. Strahlenther Onkol 196:349–355CrossRefPubMed Pez M, Keller A, Welzel G, Abo-Madyan Y, Ehmann M, Tuschy B et al (2020) Long-term outcome after intraoperative radiotherapy as a boost in breast cancer. Strahlenther Onkol 196:349–355CrossRefPubMed
23.
go back to reference Strnad V, Krug D, Sedlmayer F, Piroth MD, Budach W, Baumann R et al (2020) DEGRO practical guideline for partial-breast irradiation. Strahlenther Onkol 196:749–763CrossRefPubMedPubMedCentral Strnad V, Krug D, Sedlmayer F, Piroth MD, Budach W, Baumann R et al (2020) DEGRO practical guideline for partial-breast irradiation. Strahlenther Onkol 196:749–763CrossRefPubMedPubMedCentral
24.
go back to reference Sperk E, Astor D, Keller A, Welzel G, Gerhardt A, Tuschy B et al (2014) A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer. Radiat Oncol 9:154CrossRefPubMedPubMedCentral Sperk E, Astor D, Keller A, Welzel G, Gerhardt A, Tuschy B et al (2014) A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer. Radiat Oncol 9:154CrossRefPubMedPubMedCentral
25.
go back to reference Tuschy B, Berlit S, Nasterlack C, Tome K, Blank E, Wenz F et al (2013) Intraoperative radiotherapy of early breast cancer using low-kilovoltage x‑rays-reasons for omission of planned intraoperative irradiation. Breast J 19:325–328CrossRefPubMed Tuschy B, Berlit S, Nasterlack C, Tome K, Blank E, Wenz F et al (2013) Intraoperative radiotherapy of early breast cancer using low-kilovoltage x‑rays-reasons for omission of planned intraoperative irradiation. Breast J 19:325–328CrossRefPubMed
26.
go back to reference Vaidya JS, Baum M, Tobias JS, D’Souza DP, Naidu SV, Morgan S et al (2001) Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12:1075–1080CrossRefPubMed Vaidya JS, Baum M, Tobias JS, D’Souza DP, Naidu SV, Morgan S et al (2001) Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12:1075–1080CrossRefPubMed
27.
go back to reference Vaidya JS, Baum M, Tobias JS, Morgan S, D’Souza D (2002) The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 28:447–454CrossRefPubMed Vaidya JS, Baum M, Tobias JS, Morgan S, D’Souza D (2002) The novel technique of delivering targeted intraoperative radiotherapy (Targit) for early breast cancer. Eur J Surg Oncol 28:447–454CrossRefPubMed
28.
go back to reference Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F (2003) A novel mobile device for intraoperative radiotherapy (IORT). Onkologie 26:596–598PubMed Kraus-Tiefenbacher U, Steil V, Bauer L, Melchert F, Wenz F (2003) A novel mobile device for intraoperative radiotherapy (IORT). Onkologie 26:596–598PubMed
30.
go back to reference Kim JW, Cho Y, Choi J, Ahn SG, Jeong J, Lee IJ (2019) Redefining eligibility by analyzing canceled Intraoperative radiotherapy as a boost for patients undergoing breast-conserving treatment. Ann Surg Oncol 26:4294–4301CrossRefPubMed Kim JW, Cho Y, Choi J, Ahn SG, Jeong J, Lee IJ (2019) Redefining eligibility by analyzing canceled Intraoperative radiotherapy as a boost for patients undergoing breast-conserving treatment. Ann Surg Oncol 26:4294–4301CrossRefPubMed
31.
go back to reference Jung W, Kang E, Kim SM, Kim D, Hwang Y, Sun Y et al (2012) Factors associated with re-excision after breast-conserving surgery for early-stage breast cancer. J Breast Cancer 15:412–419CrossRefPubMedPubMedCentral Jung W, Kang E, Kim SM, Kim D, Hwang Y, Sun Y et al (2012) Factors associated with re-excision after breast-conserving surgery for early-stage breast cancer. J Breast Cancer 15:412–419CrossRefPubMedPubMedCentral
Metadata
Title
Intraoperative radiotherapy (IORT) of early breast cancer with low-energy x-rays in breast-conserving surgery
Prospective identification of pre- and intraoperative factors influencing the feasibility of IORT
Authors
Anja Grimm, MD
Eva Wollmann
Elena Sperk
Christel Weiß
Marc Sütterlin
Sebastian Berlit
Benjamin Tuschy
Publication date
04-10-2023
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 4/2024
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-023-02149-8

Other articles of this Issue 4/2024

Strahlentherapie und Onkologie 4/2024 Go to the issue